These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 14676441

  • 1. Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker.
    Lee HS, Kim WH, Kang GH.
    J Korean Med Sci; 2003 Dec; 18(6):842-8. PubMed ID: 14676441
    [Abstract] [Full Text] [Related]

  • 2. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY, Wang HL, Hart J, Fleming D, Beard MR.
    Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
    Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM.
    Am J Clin Pathol; 2004 Nov; 122(5):721-7. PubMed ID: 15491968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG, Ishizawa S, Wu E, Weiss LM.
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [Abstract] [Full Text] [Related]

  • 8. Elevated hepatocyte paraffin 1 and neprilysin expression in hepatocellular carcinoma are correlated with longer survival.
    Mondada D, Bosman FT, Fontolliet C, Seelentag WK.
    Virchows Arch; 2006 Jan; 448(1):35-45. PubMed ID: 16220294
    [Abstract] [Full Text] [Related]

  • 9. Ectopeptidases are differentially expressed in hepatocellular carcinomas.
    Röcken C, Carl-McGrath S, Gräntzdörffer I, Mantke R, Roessner A, Lendeckel U.
    Int J Oncol; 2004 Mar; 24(3):487-95. PubMed ID: 14767532
    [Abstract] [Full Text] [Related]

  • 10. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas.
    Borscheri N, Roessner A, Röcken C.
    Am J Surg Pathol; 2001 Oct; 25(10):1297-303. PubMed ID: 11688465
    [Abstract] [Full Text] [Related]

  • 11. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 12. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ.
    Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR, Susani M, Wrba F, Haitel A.
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y, Hirose T, Itoh T, Zen Y.
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [Abstract] [Full Text] [Related]

  • 16. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R, Mansoor S.
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [Abstract] [Full Text] [Related]

  • 17. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
    Nakopoulou L, Stefanaki K, Filaktopoulos D, Giannopoulou I.
    Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
    [Abstract] [Full Text] [Related]

  • 18. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 19. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
    Villari D, Caruso R, Grosso M, Vitarelli E, Righi M, Barresi G.
    Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
    [Abstract] [Full Text] [Related]

  • 20. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, Rivera MN, Ting DT, Deshpande V.
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.